vaccine for patients with newly diagnosed or recurrent low-grade glioma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for vaccine for patients with newly diagnosed or recurrent low-grade glioma, covering 2020-11-04 to 2020-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma [Phase 2]